SG11201606047RA - Ebola monoclonal antibodies - Google Patents

Ebola monoclonal antibodies

Info

Publication number
SG11201606047RA
SG11201606047RA SG11201606047RA SG11201606047RA SG11201606047RA SG 11201606047R A SG11201606047R A SG 11201606047RA SG 11201606047R A SG11201606047R A SG 11201606047RA SG 11201606047R A SG11201606047R A SG 11201606047RA SG 11201606047R A SG11201606047R A SG 11201606047RA
Authority
SG
Singapore
Prior art keywords
monoclonal antibodies
ebola monoclonal
ebola
antibodies
monoclonal
Prior art date
Application number
SG11201606047RA
Inventor
Jody Berry
Grant Mcclarty
Kelly Warfield
Aman Mohammad Javad
Original Assignee
Jody Berry
Grant Mcclarty
Kelly Warfield
Aman Mohammad Javad
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jody Berry, Grant Mcclarty, Kelly Warfield, Aman Mohammad Javad filed Critical Jody Berry
Publication of SG11201606047RA publication Critical patent/SG11201606047RA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Urology & Nephrology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Biomedical Technology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
SG11201606047RA 2014-02-19 2015-02-19 Ebola monoclonal antibodies SG11201606047RA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201461941775P 2014-02-19 2014-02-19
PCT/US2015/016702 WO2015127136A2 (en) 2014-02-19 2015-02-19 Ebola monoclonal antibodies

Publications (1)

Publication Number Publication Date
SG11201606047RA true SG11201606047RA (en) 2016-09-29

Family

ID=53879237

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201606047RA SG11201606047RA (en) 2014-02-19 2015-02-19 Ebola monoclonal antibodies

Country Status (8)

Country Link
US (1) US20170183396A1 (en)
EP (1) EP3107582A4 (en)
KR (1) KR20170047192A (en)
AU (1) AU2015218905A1 (en)
CA (1) CA2939200A1 (en)
IL (1) IL247277A0 (en)
SG (1) SG11201606047RA (en)
WO (1) WO2015127136A2 (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI710573B (en) 2015-01-26 2020-11-21 美商再生元醫藥公司 Human antibodies to ebola virus glycoprotein
GB201502209D0 (en) 2015-02-10 2015-03-25 Sec Dep For Health The And Chancellor Masters And Scholars Of The University Of Oxford The And Micro Filovirus therapy
WO2016131128A1 (en) * 2015-02-19 2016-08-25 Cangene Corporation Humanized ebola antibodies and uses thereof
CN108135994B (en) 2015-05-13 2022-01-25 宾夕法尼亚州大学信托人 AAV-mediated expression of anti-influenza antibodies and methods of use thereof
RU2644202C2 (en) * 2015-12-09 2018-02-08 федеральное государственное бюджетное учреждение"Национальный исследовательский центр эпидемиологи и микробиологии имени почетного академика Н.Ф. Гамалеи" Министерства здравоохранения Российской Федерации Single-domain antibodies to ebola virus gp protein for immunotherapy of ebola fever
RU2639533C2 (en) * 2015-12-31 2017-12-21 Федеральное государственное бюджетное образовательное учреждение высшего образования "Московский государственный университет имени М.В. Ломоносова" (МГУ) Monoclonal antibody, binding with ebola virus glycoprotein, dna fragments coding this antibody, and antigen-binding fragment
RU2630304C2 (en) * 2015-12-31 2017-09-06 Федеральное государственное бюджетное образовательное учреждение высшего образования "Московский государственный университет имени М.В. Ломоносова" (МГУ) Monoclonal antibody, binding with ebola virus glycoprotein, dna fragments coding this antibody, and antigen-binding fragment
RU2644334C2 (en) * 2016-01-19 2018-02-08 Федеральное государственное бюджетное образовательное учреждение высшего образования "Московский государственный университет имени М.В. Ломоносова" (МГУ) Monoclonal antibody, linking with e-bir virus globe-protein, dna fragments coding this antibody and antigen-binding fragment
CN105542002B (en) * 2016-02-01 2019-01-04 清华大学 A kind of monoclonal antibody Q206 and application
CN105601737B (en) * 2016-02-01 2019-01-04 清华大学 A kind of monoclonal antibody Q411 and application
WO2017192483A1 (en) * 2016-05-05 2017-11-09 Mapp Biopharmaceutical, Inc. Monoclonal antibody cocktail for treatment of ebola infections
US20190240328A1 (en) * 2016-09-24 2019-08-08 The Trustees Of The University Of Pennsylvania Novel humanized anti-ebola antibodies useful in preventing ebola infections
CA3053305A1 (en) 2017-02-17 2018-08-23 Mapp Biopharmaceutical, Inc. Monoclonal antibodies and cocktails for treatment of ebola infections
JOP20190200A1 (en) 2017-02-28 2019-08-27 Univ Pennsylvania Compositions useful in treatment of spinal muscular atrophy
FI3589730T3 (en) 2017-02-28 2024-02-22 Univ Pennsylvania Adeno-associated virus (aav) clade f vector and uses therefor
TW201837170A (en) 2017-02-28 2018-10-16 賓州大學委員會 Novel AAV mediated influenza vaccines
WO2018169785A2 (en) * 2017-03-13 2018-09-20 The Government Of The United States Of America As Represented By The Secretary Of The Army Therapeutic antibodies to marburg virus
CN106868025B (en) * 2017-03-13 2020-01-21 中国人民解放军军事医学科学院生物工程研究所 Method for preparing tripolymer Ebola virus glycoprotein mutant by using yeast
US20210208160A1 (en) * 2020-01-08 2021-07-08 The U.S.A., As Represented By The Secretary, Department Of Health And Human Services Peptides representing epitopes from filoviruses
CN114891111A (en) * 2020-12-31 2022-08-12 中元汇吉生物技术股份有限公司 Protein specifically binding to human IgG4 and application thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7250494B2 (en) * 1998-06-15 2007-07-31 Biosynexus Incorporated Opsonic monoclonal and chimeric antibodies specific for lipoteichoic acid of Gram positive bacteria
AU7089600A (en) * 1999-08-30 2001-03-26 U.S. Army Medical Research Institute Of Infectious Diseases Monoclonal antibodies and vaccines against epitopes on the ebola virus glycoprotein
US6875433B2 (en) * 2002-08-23 2005-04-05 The United States Of America As Represented By The Secretary Of The Army Monoclonal antibodies and complementarity-determining regions binding to Ebola glycoprotein
EP2262832A4 (en) * 2008-02-01 2011-03-09 Ca Minister Health & Welfare Monoclonal antibodies for ebola and marburg viruses
WO2010100056A2 (en) * 2009-03-02 2010-09-10 Stichting Top Institute Pharma Antibodies against a proliferating inducing ligand (april)

Also Published As

Publication number Publication date
WO2015127136A3 (en) 2015-10-01
CA2939200A1 (en) 2015-08-27
AU2015218905A1 (en) 2016-08-04
KR20170047192A (en) 2017-05-04
US20170183396A1 (en) 2017-06-29
EP3107582A2 (en) 2016-12-28
IL247277A0 (en) 2016-09-29
WO2015127136A2 (en) 2015-08-27
EP3107582A4 (en) 2018-02-14

Similar Documents

Publication Publication Date Title
HK1253507A1 (en) Anti-ror1 antibodies
ZA201803874B (en) Humanized anti-cd73 antibodies
HK1254836A1 (en) Anti-ror1 antibodies
HK1256116A1 (en) Anti-lag-3 antibodies
IL247277A0 (en) Ebola monoclonal antibodies
HK1258375A1 (en) Humanized anti-cll-1 antibodies
GB201521393D0 (en) Antibodies
GB201521391D0 (en) Antibodies
HK1246804A1 (en) Tau-binding antibodies
GB201521382D0 (en) Antibodies
IL253633B (en) Anti-transthyretin antibodies
IL256579A (en) Humanized antibodies
IL255323A0 (en) Anti-fcrn antibodies
HK1255056A1 (en) Anti-cd115 antibodies
IL247285A0 (en) Marburg monoclonal antibodies
PT3101131T (en) Anti-transthyretin humanized antibody
PT3250593T (en) Anti-transthyretin antibodies
PL3371216T3 (en) Humanized anti-bag3 antibodies
GB201509907D0 (en) Antibodies
GB201522394D0 (en) Antibodies
GB201511196D0 (en) Monoclonal antibodies
GB201503438D0 (en) Antibodies
IL284022B1 (en) Anti-transthyretin antibodies
GB201518728D0 (en) Antibodies
GB201515570D0 (en) Anti-LAG-3 antibodies